President & Immunovant CEO
Fri, Nov 7, 2025
Nov 7
200,000 shares @ $3.85
Increased holdings by +13.30%
87th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
36% win rate · -5.5% median edge vs SPY (76 trades, 90-day)
Insider trade was 81% below market price
Price 68% above 200-day moving average